These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 15000488

  • 1. Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy.
    Goulmy E.
    Cancer J; 2004; 10(1):1-7. PubMed ID: 15000488
    [Abstract] [Full Text] [Related]

  • 2. Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
    Zilberberg J, Feinman R, Korngold R.
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1000-7. PubMed ID: 25459643
    [Abstract] [Full Text] [Related]

  • 3. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.
    Falkenburg JH, Marijt WA, Heemskerk MH, Willemze R.
    Curr Opin Hematol; 2002 Nov; 9(6):497-502. PubMed ID: 12394171
    [Abstract] [Full Text] [Related]

  • 4. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.
    Tsirigotis P, Shimoni A, Nagler A.
    Ann Med; 2014 Sep; 46(6):384-96. PubMed ID: 24888385
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy of cancer through targeting of minor histocompatibility antigens.
    Hambach L, Goulmy E.
    Curr Opin Immunol; 2005 Apr; 17(2):202-10. PubMed ID: 15766682
    [Abstract] [Full Text] [Related]

  • 6. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
    Spierings E.
    Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
    [Abstract] [Full Text] [Related]

  • 7. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.
    Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T.
    Cancer Sci; 2007 Aug; 98(8):1139-46. PubMed ID: 17521316
    [Abstract] [Full Text] [Related]

  • 8. Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.
    Spaapen R, Mutis T.
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):543-57. PubMed ID: 18790454
    [Abstract] [Full Text] [Related]

  • 9. Minor histocompatibility antigens: past, present, and future.
    Spierings E.
    Tissue Antigens; 2014 Oct; 84(4):374-60. PubMed ID: 25262921
    [Abstract] [Full Text] [Related]

  • 10. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
    Hudecek M, Bartsch K, Tschiedel S, Niederwieser D.
    Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
    [Abstract] [Full Text] [Related]

  • 11. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells.
    Klein CA, Wilke M, Pool J, Vermeulen C, Blokland E, Burghart E, Krostina S, Wendler N, Passlick B, Riethmüeller G, Goulmy E.
    J Exp Med; 2002 Aug 05; 196(3):359-68. PubMed ID: 12163564
    [Abstract] [Full Text] [Related]

  • 12. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
    Hambach L, Ling KW, Pool J, Aghai Z, Blokland E, Tanke HJ, Bruijn JA, Halfwerk H, van Boven H, Wieles B, Goulmy E.
    Blood; 2009 Mar 19; 113(12):2715-22. PubMed ID: 19096014
    [Abstract] [Full Text] [Related]

  • 13. Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation.
    Spierings E, Goulmy E.
    Methods Mol Biol; 2012 Mar 19; 882():509-30. PubMed ID: 22665253
    [Abstract] [Full Text] [Related]

  • 14. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
    Mutis T, Blokland E, Kester M, Schrama E, Goulmy E.
    Blood; 2002 Jul 15; 100(2):547-52. PubMed ID: 12091347
    [Abstract] [Full Text] [Related]

  • 15. Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.
    Hambach L, Spierings E, Goulmy E.
    Best Pract Res Clin Haematol; 2007 Jun 15; 20(2):171-87. PubMed ID: 17448955
    [Abstract] [Full Text] [Related]

  • 16. Minor histocompatibility antigens in human stem cell transplantation.
    Falkenburg JH, van de Corput L, Marijt EW, Willemze R.
    Exp Hematol; 2003 Sep 15; 31(9):743-51. PubMed ID: 12962719
    [Abstract] [Full Text] [Related]

  • 17. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A, Oudshoorn M, Loiseau P, Dolstra H, Markiewicz M, Leffell MS, Pereira N, Kircher B, Turpeinen H, Eliaou JF, Gervais T, Laurin D, Enczmann J, Martinetti M, Thomson J, Oguz F, Santarone S, Partanen J, Siekiera U, Alessandrino EP, Kalayoglu S, Brand R, Goulmy E.
    Biol Blood Marrow Transplant; 2013 Aug 15; 19(8):1244-53. PubMed ID: 23756210
    [Abstract] [Full Text] [Related]

  • 18. Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.
    van der Torren CR, van Hensbergen Y, Luther S, Aghai Z, Rychnavská ZS, Slot M, Scherjon S, Kröger N, Ganser A, Weissinger EM, Goulmy E, Hambach L.
    PLoS One; 2015 Aug 15; 10(3):e0119595. PubMed ID: 25774796
    [Abstract] [Full Text] [Related]

  • 19. Non-myeloablative transplants for malignant disease.
    Storb RF, Champlin R, Riddell SR, Murata M, Bryant S, Warren EH.
    Hematology Am Soc Hematol Educ Program; 2001 Aug 15; ():375-91. PubMed ID: 11722994
    [Abstract] [Full Text] [Related]

  • 20. Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies.
    Mutis T, Goulmy E.
    Semin Hematol; 2002 Jan 15; 39(1):23-31. PubMed ID: 11799526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.